Literature DB >> 22537991

Factors mediating seasonal and influenza A (H1N1) vaccine acceptance among ethnically diverse populations in the urban south.

Paula M Frew1, Julia E Painter, Brooke Hixson, Carolyn Kulb, Kathryn Moore, Carlos del Rio, Alejandra Esteves-Jaramillo, Saad B Omer.   

Abstract

OBJECTIVE: We examined the acceptability of the influenza A (H1N1) and seasonal vaccinations immediately following government manufacture approval to gauge potential product uptake in minority communities. We studied correlates of vaccine acceptance including attitudes, beliefs, perceptions, and influenza immunization experiences, and sought to identify communication approaches to increase influenza vaccine coverage in community settings.
METHODS: Adults ≥18 years participated in a cross-sectional survey from September through December 2009. Venue-based sampling was used to recruit participants of racial and ethnic minorities.
RESULTS: The sample (N=503) included mostly lower income (81.9%, n=412) participants and African Americans (79.3%, n=399). Respondents expressed greater acceptability of the H1N1 vaccination compared to seasonal flu immunization (t=2.86, p=0.005) although H1N1 vaccine acceptability was moderately low (38%, n=191). Factors associated with acceptance of the H1N1 vaccine included positive attitudes about immunizations [OR=0.23, CI (0.16, 0.33)], community perceptions of H1N1 [OR=2.15, CI (1.57, 2.95)], and having had a flu shot in the past 5 years [OR=2.50, CI (1.52, 4.10). The factors associated with acceptance of the seasonal flu vaccine included positive attitudes about immunization [OR=0.43, CI (0.32, 0.59)], community perceptions of H1N1 [OR=1.53, CI (1.16, 2.01)], and having had the flu shot in the past 5 years [OR=3.53, CI (2.16, 5.78)]. Participants were most likely to be influenced to take a flu shot by physicians [OR=1.94, CI (1.31, 2.86)]. Persons who obtained influenza vaccinations indicated that Facebook (χ(2)=11.7, p=0.02) and Twitter (χ(2)=18.1, p=0.001) could be useful vaccine communication channels and that churches (χ(2)=21.5, p<0.001) and grocery stores (χ(2)=21.5, p<0.001) would be effective "flu shot stops" in their communities.
CONCLUSIONS: In this population, positive vaccine attitudes and community perceptions, along with previous flu vaccination, were associated with H1N1 and seasonal influenza vaccine acceptance. Increased immunization coverage in this community may be achieved through physician communication to dispel vaccine conspiracy beliefs and discussion about vaccine protection via social media and in other community venues.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22537991      PMCID: PMC3522428          DOI: 10.1016/j.vaccine.2012.04.053

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  72 in total

Review 1.  The determinants of 2009 pandemic A/H1N1 influenza vaccination: a systematic review.

Authors:  Stephanie Brien; Jeffrey C Kwong; David L Buckeridge
Journal:  Vaccine       Date:  2011-12-31       Impact factor: 3.641

2.  Using Facebook as an informal learning environment.

Authors:  Jeff Cain; Anne Policastri
Journal:  Am J Pharm Educ       Date:  2011-12-15       Impact factor: 2.047

3.  Integrating social media and social marketing: a four-step process.

Authors:  Rosemary Thackeray; Brad L Neiger; Heidi Keller
Journal:  Health Promot Pract       Date:  2012-03

Review 4.  Social internet sites as a source of public health information.

Authors:  Karl Vance; William Howe; Robert P Dellavalle
Journal:  Dermatol Clin       Date:  2009-04       Impact factor: 3.478

Review 5.  Factors associated with uptake of vaccination against pandemic influenza: a systematic review.

Authors:  Alison Bish; Lucy Yardley; Angus Nicoll; Susan Michie
Journal:  Vaccine       Date:  2011-07-12       Impact factor: 3.641

6.  Adoption and use of social media among public health departments.

Authors:  Rosemary Thackeray; Brad L Neiger; Amanda K Smith; Sarah B Van Wagenen
Journal:  BMC Public Health       Date:  2012-03-26       Impact factor: 3.295

7.  Trends in risk perceptions and vaccination intentions: a longitudinal study of the first year of the H1N1 pandemic.

Authors:  Courtney A Gidengil; Andrew M Parker; Brian J Zikmund-Fisher
Journal:  Am J Public Health       Date:  2012-02-16       Impact factor: 9.308

8.  The efficacy of social role models to increase motivation to obtain vaccination against hepatitis B among men who have sex with men.

Authors:  R Vet; J B F de Wit; E Das
Journal:  Health Educ Res       Date:  2010-11-24

9.  Swine influenza A (H1N1) infection in two children--Southern California, March-April 2009.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2009-04-24       Impact factor: 17.586

10.  Monitoring the level of government trust, risk perception and intention of the general public to adopt protective measures during the influenza A (H1N1) pandemic in The Netherlands.

Authors:  Willemien van der Weerd; Daniëlle Rm Timmermans; Desirée Jma Beaujean; Jurriaan Oudhoff; Jim E van Steenbergen
Journal:  BMC Public Health       Date:  2011-07-19       Impact factor: 3.295

View more
  29 in total

1.  Clinician perspectives on strategies to improve patient maternal immunization acceptability in obstetrics and gynecology practice settings.

Authors:  Paula M Frew; Laura A Randall; Fauzia Malik; Rupali J Limaye; Andrew Wilson; Sean T O'Leary; Daniel Salmon; Meghan Donnelly; Kevin Ault; Matthew Z Dudley; Vincent L Fenimore; Saad B Omer
Journal:  Hum Vaccin Immunother       Date:  2018-02-15       Impact factor: 3.452

2.  Influenza vaccination acceptance among diverse pregnant women and its impact on infant immunization.

Authors:  Paula M Frew; Siyu Zhang; Diane S Saint-Victor; Ashley C Schade; Samantha Benedict; Maral Banan; Xiang Ren; Saad B Omer
Journal:  Hum Vaccin Immunother       Date:  2013-10-30       Impact factor: 3.452

3.  Influenza vaccine hesitancy in a low-income community in central New York State.

Authors:  Manika Suryadevara; Cynthia A Bonville; Paula F Rosenbaum; Joseph B Domachowske
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 4.  Utilizing health information technology to improve vaccine communication and coverage.

Authors:  Melissa S Stockwell; Alexander G Fiks
Journal:  Hum Vaccin Immunother       Date:  2013-06-04       Impact factor: 3.452

5.  A randomized trial of maternal influenza immunization decision-making: A test of persuasive messaging models.

Authors:  Paula M Frew; Jennifer L Kriss; Allison T Chamberlain; Fauzia Malik; Yunmi Chung; Marielysse Cortés; Saad B Omer
Journal:  Hum Vaccin Immunother       Date:  2016-08-02       Impact factor: 3.452

6.  Message framing strategies to increase influenza immunization uptake among pregnant African American women.

Authors:  Heather A Marsh; Fauzia Malik; Eve Shapiro; Saad B Omer; Paula M Frew
Journal:  Matern Child Health J       Date:  2014-09

7.  Influenza vaccination coverage among school employees: assessing knowledge, attitudes, and behaviors.

Authors:  Marie A de Perio; Douglas M Wiegand; Scott E Brueck
Journal:  J Sch Health       Date:  2014-09       Impact factor: 2.118

8.  Factors associated with seasonal influenza immunization among church-going older African Americans.

Authors:  Sahithi Boggavarapu; Kevin M Sullivan; Jay T Schamel; Paula M Frew
Journal:  Vaccine       Date:  2014-11-05       Impact factor: 3.641

9.  The Influence of Health Messaging Source and Frequency on Maternal Smoking and Child Exposure among Low-Income Mothers.

Authors:  Amy M Lavery; Uma Nair; Sarah Bauerle Bass; Bradley N Collins
Journal:  J Commun Healthc       Date:  2016-09-19

10.  Disparities in influenza vaccination coverage among women with live-born infants: PRAMS surveillance during the 2009-2010 influenza season.

Authors:  Indu B Ahluwalia; Helen Ding; Leslie Harrison; Denise D'Angelo; James A Singleton; Carolyn Bridges
Journal:  Public Health Rep       Date:  2014 Sep-Oct       Impact factor: 2.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.